e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diffuse parenchymal lung disease I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of pregnancy on pulmonary function in women with pulmonary Langerhans cell histiocytosis
E. Radzikowska, M. Franczuk, E. Wiatr, I. Bestry, R. Langfort, K. Roszkowski-Sliz (Warsaw, Poland)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease I
Session:
Diffuse parenchymal lung disease I
Session type:
Thematic Poster Session
Number:
2357
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Radzikowska, M. Franczuk, E. Wiatr, I. Bestry, R. Langfort, K. Roszkowski-Sliz (Warsaw, Poland). Influence of pregnancy on pulmonary function in women with pulmonary Langerhans cell histiocytosis. Eur Respir J 2013; 42: Suppl. 57, 2357
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Related content which might interest you:
Smoking status and long term clinical outcome in patients with pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH)
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis
Source: Eur Respir Mon 2012; 57: 161-165
Year: 2012
Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in patients with pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Longitudinal change in non-invasive markers in interstitial lung disease associated pulmonary hypertension and correlation with invasive pulmonary haemodynamics
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Interstitial lung disease in elderly subjects
Source: Eur Respir Mon; 2009: 43: 150–162
Year: 2009
Steroid treatment effect in pulmonary sarcoidosis (STEPS study)
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Pulmonary hypertension in orphan lung diseases
Source: Eur Respir Mon 2011; 54: 317-331
Year: 2011
Women and interstitial lung diseases
Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=167
Year: 2003
Smoking-related interstitial lung diseases: a concise review
Source: Eur Respir J 2001; 17: 122-132
Year: 2001
Cardiorespiratory responses to incremental exercise in patients with pulmonary Langerhans' cell histiocytosis
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Assessment of nutritional status in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013
Diffuse pulmonary ossification
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept